TRANSDERMAL ABSORPTION PREPARATION

摘要

A transdermal absorption preparation controlling the drug concentration in blood which contains an ester compound of 4-{[2-(1R,2R, 3R)-3-hydroxy-2-{(1E,3S)-3-hydroxy-4-[3-(methoxymethyl)phenyl]buta-1-enyl}-5-oxocyclopentyl)ethyl]sulfanyl}butanonic acid. This transdermal absorption preparation controlling the drug concentration in blood makes it possible to stably sustain the concentration of the active compound in the blood and is highly safe without showing any side effects. Therefore, it is usable as a transdermal absorption preparation which can be continuously administered.